Luda Technology Group Limited (LUD.US) Reports Significant Gains from Strategic Equity Investment Portfolio for Eleven Months Ended November 30, 2025
HONG KONG, Dec. 16, 2025 /PRNewswire/ -- Luda Technology Group Limited and its subsidiaries ("Luda Technology" or the "Company", NYSE: LUD.US) announced that its strategic equity investment portfolio delivered strong performance for the eleven...
AI Robotmaker Sharpa Reaches Key Milestone With Mass Production of World's Most Advanced Human-Sized Robotic Hand
SINGAPORE, Dec. 16, 2025 /PRNewswire/ -- Sharpa, a Singapore-headquartered AI robotics firm, has achieved a major milestone with the launch of mass production for SharpaWave, its flagship robotic hand engineered to match the size and dexterity of...
Final Report Meeting on the Achievements of the Cheongju Craft Biennale 2025: Record-Breaking Economic Impact
- The achievement analysis report meeting took place on Wednesday, December 10, at 4:00 pm in the fourth-floor conference room of the Main Building, Culture Factory. - Visitor satisfaction reached 90.3%, and the economic ripple effect increased to...
Anker Celebrates the Year-End in Malaysia on Next-Gen Charging, Audio, and Smart Home Innovations
Anker rolls out its most exciting lineup yet this year-end promotion, featuring special offers across its latest Nano Series chargers, soundcore audio innovations, and eufy smart home devices KUALA LUMPUR, Malaysia, Dec. 12, 2025 /PRNewswire/ -- As...
NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO
Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients with advanced or metastatic solid tumors, including those who have relapsed or are refractory to checkpoint inhibitors, a multi-billion dollar pillar of cancer care,...
Leading the K-PET Trend: Korean Pet Brand 'Bremen' Premium Roasted Hwangtae Snack for Pets and Owners Launches on Makuake December 10
SEOUL, South Korea, Dec. 10, 2025 /PRNewswire/ -- Bremen Co., Ltd., a leading Korean pet specialty company, is expanding into Japan with its premium treat, the Bremen Roasted Hwangtae Snack. Created for safe and shared enjoyment by both pets and...
Innovent Announces PECONDLE® (Picankibart Injection) Phase 3 Study (CLEAR-2) Meets Endpoints, Delivering Superior Long-Term Management Solution for Moderate-to-Severe Psoriasis
SAN FRANCISCO and SUZHOU, China, Dec. 9, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025
– New findings demonstrate a 72% HI-E response rate at Week 16 with meaningful hemoglobin improvement – – Strong activity observed across ESA-refractory and ESA-intolerant patients, and across mutation and morphology subtypes – – Favorable safety...
51Talk Online Education Group Announces Third Quarter 2025 Results
SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, announced its unaudited results for the third...
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure frequency (CMSF) compared with placebo1 Holistic benefit: secondary endpoints showed significant...